M2RLAB SL
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery (NCT07052513) | M2RLAB SL | 2025-12-14 |
Track M2RLAB SL automatically
Every clearance here is in the API, with alerts when new ones post.